Singapore’s NUS Integrates AI and 3D Bioprinting to Transform Personalised Gum Tissue Grafts

Artificial intelligence streamlines the optimisation of bioprinting parameters for oral soft tissue grafts, reducing time and resourc...

April 04, 2025 | Friday | Reports
Novo Nordisk’s Semaglutide 2.4 mg Linked to 57% Reduction in Cardiovascular Events in Real-World SCORE Study

Novo Nordisk announced new findings from the retrospective, observational SCORE study, demonstrating that treatment with semaglutide 2.4 mg was associate...

March 31, 2025 | Monday | News
Medtronic’s Evolut TAVR Demonstrates Durable Outcomes at Five Years in Low-Risk Patients with Severe Aortic Stenosis

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. D...

March 31, 2025 | Monday | News
B. Braun Launches 3 g Cefazolin in DUPLEX® for Surgical Infection Prevention

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced the launch of its new Cefazolin 3 g, the latest cefazol...

March 25, 2025 | Tuesday | News
Moon Surgical Secures FDA Clearance for ScoPilot, First AI-Powered Intraoperative Tool

Moon Surgical, a French-American pioneer in surgical innovation, announced the United States Food and Drug Administration (FDA) clearance for ScoPilot. Ena...

March 20, 2025 | Thursday | News
Laplace Interventional Secures Series C Financing to Advance Transcatheter Tricuspid Valve Technology

The Series C financing was led by a global strategic investor along with participation from new investors Aphelion Cardeation and Unorthodox Ventures. Ex...

March 17, 2025 | Monday | News
BD Reports Strong Q1 2025 Results with $5.2B Revenue as CEO Tom Polen Announces Strategic Business Separation

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company,  announced its financial results for the first quarter ...

February 06, 2025 | Thursday | Company results
Kardigan Launches with $300 Million Series A to Transform Cardiovascular Disease Treatment

Company embarks on a vision to make cardiovascular disease curable, preventable, and no longer the leading cause of death worldwide Led by found...

January 13, 2025 | Monday | News
QIAcuity Digital PCR Expands Capacity to 12 Targets Simultaneously with New Software Update and High Multiplex PCR Kit

  QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold inc...

January 13, 2025 | Monday | News
Smith+Nephew Expands CORI◊ Surgical System Portfolio with FDA-Cleared CORIOGRAPH Pre-Op Planning for Hip Arthroplasty

Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for patients and surgeons Smith+Nephew (LSE:SN, NYSE:SNN),...

December 20, 2024 | Friday | News
Siemens Healthineers and DeepHealth Collaborate to Launch AI-Powered SmartTechnology™ for Enhanced Ultrasound Diagnostics

Siemens Healthineers and DeepHealth have signed a letter of intent to create AI-powered SmartTechnology™ to improve patient experience and operat...

December 02, 2024 | Monday | News
Deepull Secures FDA Breakthrough Device Designation for Transformative Bloodstream Infection Test

deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification, announced that it has receive...

December 02, 2024 | Monday | News
NurExone Gains EMA Orphan Designation for ExoPTEN, Advancing Spinal Cord Injury Therapy Across Europe

NurExone Biologic Inc.  a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce that the European Medici...

November 14, 2024 | Thursday | News
Hexagon Health Sues Medtronic for Alleged Patent Infringement on Hernia Mesh Technology

The suit alleges Medtronic violated Hexagon Health's patents in developing and selling Dextile, a hernia mesh repair device.  Hexagon Health Inc. a...

November 14, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close